11 insiders have filed at IOVA since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Rothbaum Wayne P. | Director | 28.07M | 6.706% | 2 buys $72.3M | |
| Mcpeak Merrill A | Director | 568.8k | 0.136% | 2 buys $2.3M | |
| Vogt Frederick G | Interim CEO & General Counsel | 529.5k | 0.127% | 1 buys $42k | |
| Puri Raj K. | Chief Regulatory Officer | 239.2k | 0.057% | 1 buys $10k | |
| Kirby Daniel Gordon | Chief Commercial Officer | 139.4k | 0.033% | 1 buys $55k | |
| Graf Finckenstein Friedrich | Chief Medical Officer | 132.0k | 0.032% | ||
| Bilinsky Igor | Chief Operating Officer | 125.8k | 0.03% | ||
| Rosinack Matthew W. | SVP, Finance (int. Pfo & Pao) | 89.1k | 0.021% | ||
| Bellemin Jean-Marc | Chief Financial Officer | 60.5k | 0.014% | ||
| Dukes Iain D. | Director | 54.0k | 0.013% | 1 buys $293k | |
| Maynard Ryan D | Director | 7.5k | <0.01% | 1 sells $503k |
Full register at boothcheck.com/insiders/IOVA. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.